U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219472) titled 'Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy' on Oct. 20.
Brief Summary: This research study is for people who have a condition called chemotherapy-induced peripheral neuropathy (CIPN). This condition develops as a result of receiving medication(s) to treat cancer, particularly chemotherapy. CIPN is characterized by pain, numbness, tingling or burning sensations, typically in the hands and feet of people. These symptoms can lead to physical suffering, limited ability to perform daily activities, and low quality of life. One of the ways to treat CIPN is using a device called Scrambler Therapy. Scrambler Therapy wa...